Kangstem Biotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	338,595	129,871	113,077	91,090	-	-
Market Cap Growth	170.87%	14.85%	24.14%	-	-	-
Enterprise Value	309,841	111,660	94,866	86,880	-	-
Last Close Price	3600.00	2320.00	1689.51	2003.15	2103.33	2375.78
PS Ratio	94.78	36.35	14.60	7.17	-	-
PB Ratio	4.90	1.88	2.62	1.82	-	-
P/TBV Ratio	6.49	2.49	2.68	1.92	-	-
EV/Sales Ratio	86.73	31.26	12.25	6.84	-	-
Debt / Equity Ratio	0.14	0.14	0.20	0.27	0.25	0.20
Net Debt / Equity Ratio	-0.42	-0.42	-0.23	-0.47	-0.44	-0.60
Net Debt / EBITDA Ratio	1.91	1.91	0.85	1.26	1.40	2.26
Net Debt / FCF Ratio	2.36	2.36	0.50	1.33	1.19	1.97
Asset Turnover	0.05	0.05	0.11	0.16	0.18	0.13
Inventory Turnover	3.26	3.26	4.76	21.16	18.57	17.37
Quick Ratio	4.75	4.75	2.92	2.07	2.73	3.38
Current Ratio	5.25	5.25	3.69	2.55	3.22	3.80
Return on Equity (ROE)	-18.65%	-18.65%	-15.18%	-45.17%	-32.55%	-36.40%
Return on Assets (ROA)	-16.06%	-16.06%	-13.52%	-17.59%	-13.99%	-15.31%
Return on Capital Employed (ROCE)	-24.10%	-24.10%	-30.80%	-36.40%	-31.00%	-26.40%
Earnings Yield	-3.10%	-8.07%	-6.78%	-24.10%	-	-
FCF Yield	-3.64%	-9.50%	-17.32%	-19.64%	-	-
Buyback Yield / Dilution	-53.92%	-23.10%	-38.90%	-7.02%	-36.23%	-24.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.